Evidence map›Paper›PMID 23243065›Full record

ReviewEukaryotic cell2013

Translational control in Plasmodium and toxoplasma parasites.

Min Zhang, Bradley R Joyce, William J Sullivan, Victor Nussenzweig

Abstract readReview
In one paragraph

Review in Eukaryotic cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. TwoResearch square · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Identification ofmSphere · 2023
    Article
  10. Review
  11. Unravelling the sexual developmental biology ofFrontiers in cellular and infection microbiology · 2023
    Article
  12. Article
  13. The determinants regulatingFrontiers in microbiology · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Min ZhangDepartment of Pathology, New York University School of Medicine, New York, New York, USA. Dr.Min.Zhang@gmail.com
Bradley R Joyce
William J Sullivan
Victor Nussenzweig

Funding

GCN5-mediated transcription in AIDS pathogen ToxoplasmaR01AI077502 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI SULLIVAN, WILLIAM J · 2009 to 2013
$1.8M
Translational control and latent Toxoplasma infectionR21AI084031 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI SULLIVAN, WILLIAM J, WEK, RONALD C · 2009 to 2010
$422k
GCN5-mediated transcription in AIDS pathogen ToxoplasmaR56AI077502 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI SULLIVAN, WILLIAM J · 2008 to 2008
$308k
Stress responses in the AIDS opportunistic parasite Toxoplasma gondiiF32AI093271 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI JOYCE, BRAD R · 2011 to 2012
$112k
NIAID NIH HHS AI077502NIAID NIH HHS AI084031NIAID NIH HHS AI093271NIAID NIH HHS F32 AI093271NIAID NIH HHS R01 AI077502NIAID NIH HHS R21 AI084031NIAID NIH HHS R56 AI077502
6 · The paper itself

Abstract

The life cycles of apicomplexan parasites such as Plasmodium spp. and Toxoplasma gondii are complex, consisting of proliferative and latent stages within multiple hosts. Dramatic transformations take place during the cycles, and they demand precise control of gene expression at all levels, including translation. This review focuses on the mechanisms that regulate translational control in Plasmodium and Toxoplasma, with a particular emphasis on the phosphorylation of the α subunit of eukaryotic translation initiation factor 2 (eIF2α). Phosphorylation of eIF2α (eIF2α∼P) is a conserved mechanism that eukaryotic cells use to repress global protein synthesis while enhancing gene-specific translation of a subset of mRNAs. Elevated levels of eIF2α∼P have been observed during latent stages in both Toxoplasma and Plasmodium, indicating that translational control plays a role in maintaining dormancy. Parasite-specific eIF2α kinases and phosphatases are also required for proper developmental transitions and adaptation to cellular stresses encountered during the life cycle. Identification of small-molecule inhibitors of apicomplexan eIF2α kinases may selectively interfere with parasite translational control and lead to the development of new therapies to treat malaria and toxoplasmosis.

Indexed as

Protein BiosynthesisAnimalsEukaryotic Initiation Factor-2Gene Expression RegulationHost-Parasite InteractionsHumansMalariaPhosphorylationPlasmodiumProtein Processing, Post-TranslationalProtozoan ProteinsSporozoitesToxoplasmaToxoplasmosisEukaryotic Initiation Factor-2Protozoan Proteins

Identifiers

PMID23243065
PMCPMC3571306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.